New Crown Vaccine | The United States resumes recommending vaccinations against Johnson & Johnson

Instant International

Written by: Hong Yilin

2021-04-24 08:56

Last update date: 2021-04-24 08:56

After the US Centers for Disease Control and Prevention (CDC) expert panel recommended the resumption of vaccination against Johnson & Johnson's new coronavirus pneumonia (COVID-19) on April 23, the CDC and the Food and Drug Administration (FDA) announced on the same day Lift the proposal to suspend the injection of Johnson & Johnson vaccine.

The FDA issued an announcement on the same day that after the data evaluation, various agencies emphasized their confidence in the safety and efficacy of the vaccine. Existing data indicate that thrombosis is very rare.

↓If you want to know the life of the American people during the epidemic, please click to enlarge and watch:

The announcement stated that after an in-depth safety review, the Food and Drug Administration and the Centers for Disease Control and Prevention decided to remove the relevant recommendations.

New crown pneumonia | US expert group recommends resuming Johnson & Johnson vaccination

New crown pneumonia | European Medicines Agency: Johnson & Johnson vaccine may be related to thrombosis, reiterated that the benefits outweigh the disadvantages

New crown vaccine | Pfizer BioNTech delivers EU vaccine early to make up for J&J’s shortage of supply

New crown pneumonia | Some countries suspend the use of Johnson & Johnson vaccine, European Medicines Agency announces results of review next week

Someone died after being vaccinated by Johnson & Johnson, which led to the suspension of the Johnson & Johnson vaccination in the United States.

The expert team of the Centers for Disease Control and Prevention met earlier the same day to examine the cases related to thrombosis, and then decided to recommend the resumption of vaccination.

New Coronary Pneumonia New Coronary Vaccine US Outbreak (New Coronary Pneumonia) Global Outbreak Johnson & Johnson USA